or Try an Advanced Search...

    Genetic Testing Stocks List

    Symbol Grade Name % Change
    NTRA B Natera, Inc. 2.65
    PRE C Prenetics Global Limited -0.43
    FLGT C Fulgent Genetics, Inc. 0.75
    AWH D Aspira Women's Health Inc. 0.00
    NEOG D Neogen Corporation 1.12
    OSUR F OraSure Technologies, Inc. 2.58
    GENE F Genetic Technologies Ltd 0.00
    ME F 23andMe Holding Co. 0.00
    View As Page of Charts
    Related Industries: Diagnostics & Research Medical Instruments & Supplies
    Related Stock Lists: Medical Test Applied Genetics Genetics Medical Genetics Medicine Biotechnology Genomics Biology Cancer Clinical Medicine DNA DNA Paternity Testing Diagnostic Products FDA Genetic Testing Services Immunoassay Ovarian Cancer Pharmacogenomics Toxicology Acid

    Related ETFs - A few ETFs which own one or more of the above listed Genetic Testing stocks.

    Symbol Grade Name Weight
    GNOM F Global X Genomics & Biotechnology ETF 5.6
    EKG D First Trust Nasdaq Lux Digital Health Solutions ETF 4.08
    ATFV B Alger 25 ETF 3.94
    HELX D Franklin Genomic Advancements ETF 3.8
    ARKG D ARK Genomic Revolution Multi-Sector ETF 3.75
    View all Genetic Testing ETFs...
    Compare ETFs
    Compare EKG to ATFV Compare GNOM to EKG Compare GNOM to HELX

        Genetic Testing Stocks Recent News

        Date Stock Title
        Nov 1 NTRA Natera to Report its Third Quarter 2024 Results on November 12, 2024
        Nov 1 FLGT Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains?
        Nov 1 OSUR Promising Penny Stocks On US Exchanges In November 2024
        Oct 31 NTRA Natera And GeneDx: Outperforming Market Powered By Precision Medicines Tailwinds
        Oct 31 ME 23andMe turns to CFOs to fill director roles after mass board exit
        Oct 31 FLGT Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1
        Oct 31 ME 23andMe appoints three former CFOs as new directors—after the previous board all resigned
        Oct 30 ME 23andMe regains compliance with Nasdaq listing requirements
        Oct 30 ME 23andMe Regains Compliance With Nasdaq Listing Requirements
        Oct 30 NTRA Loss-Making Natera, Inc. (NASDAQ:NTRA) Expected To Breakeven In The Medium-Term
        Oct 29 ME 23andMe Appoints Three New Independent Directors to Board
        Oct 28 ME Ancestry Says a 23AndMe Takeover Would Raise Antitrust Issues
        Oct 27 NTRA Natera: A Genetic Investment Worth Watching And Holding
        Oct 27 ME 23andMe: Liquidity Pressures And Operational Instability Pose Significant Risks
        Related Industries: Diagnostics & Research Medical Instruments & Supplies
        Related Stock Lists: Medical Test Applied Genetics Genetics Medical Genetics Medicine Biotechnology Genomics Biology Cancer Clinical Medicine DNA DNA Paternity Testing Diagnostic Products FDA Genetic Testing Services Immunoassay Ovarian Cancer Pharmacogenomics Toxicology Acid
        Genetic Testing

        Genetic testing is a type of medical test that looks at a person’s genes to identify changes that may be associated with a medical condition. It can be used to diagnose a variety of conditions, including inherited diseases, birth defects, and other health problems. It can also be used to determine a person’s risk of developing certain diseases in the future.

        Browse All Tags